期刊文献+

老年性痴呆的维吾尔医证候分类及用药规律分析

Uyghur Medicine Syndrome Classification of Alzheimer's disease and Its Medication Discipline
下载PDF
导出
摘要 目的:整理分析维吾尔医辨证施治老年性痴呆的证候分类及维吾尔药用药规律。方法:采用回顾性整理分析方法,收集整理新疆维吾尔自治区维吾尔医医院2010年1月至2014年12月期间确诊为老年性痴呆的患者住院病历,整理分析老年性痴呆的维吾尔医证候分类与治疗原则、方法、方药及其用药情况。结果:符合纳入标准的老年性痴呆病历有220例,其中异常黏液质111例(50.5%),异常黑胆质66例(30.0%),异常胆液质34例(15.5%),异常血液质9例(4.1%)。采用成熟及清除疗法,内服药物疗法,外用药物疗法和非药物疗法等综合治疗方法进行治疗。结论:老年性痴呆的维吾尔医证候分类及用药规律符合临床辨证实际,为维吾尔医辨证施治的规范化提供了客观依据。 Objective: To collate and analyze the uyghur medicine syndrome classification of Alzheimer's disease and its medication discipline. Method: Using retrospective analysis of sorting,clinical medical records of Alzheimer's disease treated with Uyghur medicine within recent 4 years in Uyghur medicine hospitals were co1 lected. Uyghur medical symptom classification and treatment principles,methods,prescriptions and medications of Alzheimer 's disease were collated and analyzed to discover Alzheimer 's disease's Uyghur medicine syndrome differentiation method and its medication discipline. Result: Among 220 cases of medical records meeting the inclusion criteria of Alzheimer's disease,there were 111 cases( 50. 5%) of abnormal Phlgam type,followed by 66 cases( 30. 0%) of abnormal Savda type,34cases( 15. 5%) of abnormal Sapra type,9 cases( 4. 1%) of abnormal Khan type. Patients were treated with Munzij Therapy or conditioning,Mushil Therapy,oral medication,topical medications and non—drug therapy of Uyghur Medicine. Conclusion: Uyghur medicine syndrome Classification and medication discipline of Alzheimer's disease received in this project is in line with the actual clinical syndrome and that provides an objective basis for standardization of Alzheimer's disease's Uyghur medicine syndrome differentiation。
出处 《中国民族医药杂志》 2016年第5期14-17,共4页 Journal of Medicine and Pharmacy of Chinese Minorities
基金 新疆维吾尔自治区公益性项目(KY2014069)
关键词 老年性痴呆 证候分类 维吾尔医用药规律 临床病历整理 Alzheimer's disease Syndrome Classification medication discipline Clinical records collating
  • 相关文献

参考文献14

  • 1雷洪涛,李新民.中医治疗阿尔茨海默病研究进展[J].辽宁中医药大学学报,2012,14(9):215-217. 被引量:12
  • 2LiSQ’Yu Y,Han JZ,et al. Deficiency of macrophage mi-gration inhibitory factor attenuates tau hyperphosphorylationin mouse models of Alzheimer,s disease [ J]. J Neuroin-flammation. 2015,12(1) :177 -178. PMID: 26382037.
  • 3Kosicek M, Hecimovic S,et al. Phospholipids and Alzhei-mer* s Disease : alterations, mechanisms and potential bio-markers[J]. Int J Mol Sci. 2013 ,14 ( 1) ; 1310 - 1322.PMID: 23306153.
  • 4Hanger DP, Anderton BH, Noble W, et al. Tau phospho-rylation :the therapeutic challenge for neurodegenerativedisease [ J ]. Trends Mol Med. 2009,15 ( 3 ) : 112 - 114.PMID: 19246243.
  • 5董贤慧,柴锡庆.阿尔茨海默病发病机制研究进展[J].中国老年学杂志,2014,34(20):5906-5912. 被引量:42
  • 6Hanger DP, Anderton BH, Noble W, et al. Tau phospho-rylation :the therapeutic challenge for neurodegenerativedisease [J]. Trends Mol Med. 2009,15 (3 ) : 112 - 114_PMID: 19246243.
  • 7梁娟芳,郭君伟,付宝,刘越泽.中西医结合治疗阿尔茨海默病疗效的meta分析[J].山西医科大学学报,2014,45(3):209-212. 被引量:10
  • 8王明华,罗榕,梁晶晶.中西医结合治疗老年性痴呆的临床疗效探讨[J].西部医学,2012,24(6):1105-1106. 被引量:5
  • 9张贺,何晓云,黄永茂.治疗老年痴呆药物研究[J].中华实用医药杂志,2008,8(8) :64 -65.
  • 10阿不力克木.努尔买买提阿吉,阿不力米提.穆哈木德等.维吾尔医内科学[M].新躇维吾尔医学专科学校编印,2008:81 -84.

二级参考文献69

共引文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部